Outcomes Following Treatment of Maternal Hypercalcemia Due to CYP24A1 Pathogenic Variants

Kidney Int Rep. 2019 Mar 8;4(6):888-892. doi: 10.1016/j.ekir.2019.02.018. eCollection 2019 Jun.

Authors

Lucy McBride¹, Christine Houlihan¹, Catherine Quinlan^{2

3

4}, Betty Messazos⁵, Zornitza Stark^{3

4

6}, Amy Crosthwaite¹

Affiliations

¹ Department of Obstetrics and Gynaecology, Mercy Hospital for Women, Melbourne, Australia.
² Department of Nephrology, Royal Children's Hospital, Melbourne, Australia.
³ Murdoch Children's Research Institute, Melbourne, Australia.
⁴ Department of Paediatrics, University of Melbourne, Australia.
⁵ Department of Endocrinology and Diabetes, Royal Children's Hospital, Melbourne, Australia.
⁶ Victorian Clinical Genetics Services, Melbourne, Australia.

No abstract available

Publication types

Case Reports